EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population

Satoshi Sato, Chikara Iino, Takafumi Sasada, Keisuke Furusawa, Kenta Yoshida, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakuraba

Environmental Health and Preventive Medicine · 2025

DOI: 10.1265/ehpm.24-00365 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Environmental Health and Preventive Medicine, 2025. Verfasst von Satoshi Sato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Membrane Proteins, Lipase, Liver Cirrhosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Many factors are associated with the development and progression of liver fat and fibrosis; however, genetics and the gut microbiota are representative factors. Moreover, recent studies have indicated a link between host genes and the gut microbiota. This study investigated the effect of patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 (C > G), which has been reported to be most involved in the onset and progression of fatty liver, on liver fat and fibrosis in a cohort study related to gut microbiota in a non-fatty liver population. METHODS: This cohort study included 214 participants from the health check-up project in 2018 and 2022 who had non-fatty liver with controlled attenuation parameter (CAP) values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMembrane ProteinsLipaseLiver CirrhosisNon-alcoholic Fatty Liver DiseaseHumansMaleFemaleMiddle AgedCohort StudiesGenotypeAdultPolymorphism, Single NucleotideAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

Cohort studyGut microbiotaLiver fatLiver fibrosisPatatin-like phospholipase domain-containing 3 (PNPLA3)

Substanzen

PNPLA3 protein, humanMembrane ProteinsLipaseAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Department of Gastroenterology, Hematology and Clinical Immunology, Hirosaki University Graduate School of Medicine.
  • Department of Preemptive Medicine, Hirosaki University Graduate School of Medicine.

Zitieren

APA

Sato, S., Iino, C., Sasada, T., Furusawa, K., Yoshida, K., Sawada, K., Mikami, T., Fukuda, S., Nakaji, S., & Sakuraba, H. (2025). A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population. Environmental Health and Preventive Medicine. https://doi.org/10.1265/ehpm.24-00365

Vancouver

Sato S, Iino C, Sasada T, Furusawa K, Yoshida K, Sawada K, et al. A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population. Environmental Health and Preventive Medicine. 2025. doi:10.1265/ehpm.24-00365

BibTeX
@article{Sato2025,
  author = {Sato, Satoshi and Iino, Chikara and Sasada, Takafumi and Furusawa, Keisuke and Yoshida, Kenta and Sawada, Kaori and Mikami, Tatsuya and Fukuda, Shinsaku and Nakaji, Shigeyuki and Sakuraba, Hirotake},
  title = {A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population},
  journal = {Environmental Health and Preventive Medicine},
  year = {2025},
  doi = {10.1265/ehpm.24-00365}
}
Kostenlos starten →